VC
REPL icon

Vestor Capital’s Replimune Group REPL Stock Holding History

Vestor Capital’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103K Buy
+557
New +$3.41K 0.01% 197
2026
Q1 		– Sell
-400
Closed -$43K – 291
2025
Q4 		$43K Buy
+400
New +$3.4K ﹤0.01% 258

Other funds holding REPL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
RCI
Ridgeback Capital Investments Miami Beach, Florida $80.9M AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Vestor Capital's REPL Position: Q2 2026 in Review

Vestor Capital opened a new position in Replimune Group (REPL) in Q2 2026: 557 shares worth $103K. The stake represents 0.01% of the portfolio and ranks #197 among its holdings. This is a return to the name: Vestor Capital previously reported a position in REPL as recently as Q4 2025.

Vestor Capital first reported a position in REPL in Q4 2025 and has held it in 2 quarters since. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Vestor Capital held 557 shares of Replimune Group worth $103K as of Q2 2026.
  • Replimune Group was a new Vestor Capital position in Q2 2026.
  • Replimune Group made up 0.01% of Vestor Capital's portfolio in Q2 2026, its #197 holding.
  • Vestor Capital first reported a position in Replimune Group in Q4 2025 and has held it in 2 quarters since.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Vestor Capital's 13F filing for Q2 2026, filed 28 Jul 2026.